| Pharmacogenetic Analysis of TNF, TNFRSF1A, and TNFRSF1B Gene Polymorphisms and Prediction of Response to Anti-TNF Therapy in Psoriasis Patients in the … Y Vasilopoulos, M Manolika, E Zafiriou, T Sarafidou, V Bagiatis, ... Molecular diagnosis & therapy 16, 29-34, 2012 | 100 | 2012 |
| Objective biophysical findings in patients with sensitive skin. AV Roussaki-Schulze, E Zafiriou, D Nikoulis, E Klimi, E Rallis, E Zintzaras Drugs under experimental and clinical research 31, 17-24, 2005 | 92 | 2005 |
| Recombinant interferon beta gel as an adjuvant in the treatment of recurrent genital warts: results of a placebo-controlled double-blind study in 120 patients G Gross, T Rogozinski, H Schöfer, S Jablonska, A Roussaki, C Wöhr, ... Dermatology 196 (3), 330-334, 1998 | 88 | 1998 |
| Systemic treatment of condylomata acuminata with recombinant interferon-alpha-2a: low-dose superior to the high-dose regimen G Gross, H Ikenberg, A Roussaki, N Drees, E Schöpf Chemotherapy 32 (6), 537-541, 1986 | 86 | 1986 |
| Netherton syndrome: a genotype-phenotype review CA Sarri, A Roussaki-Schulze, Y Vasilopoulos, E Zafiriou, A Patsatsi, ... Molecular diagnosis & therapy 21, 137-152, 2017 | 85 | 2017 |
| Epidermodysplasia verruciformis in a patient with Hodgkin's disease: characterization of a new papillomavirus type and interferon treatment G Gross, K Ellinger, A Roussaki, PG Fuchs, HH Peter, H Pfister Journal of investigative dermatology 91 (1), 43-48, 1988 | 85 | 1988 |
| IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17-and IFNγ-producing T cells A Mavropoulos, A Varna, E Zafiriou, C Liaskos, I Alexiou, ... Clinical Immunology 184, 33-41, 2017 | 82 | 2017 |
| Evaluation of cytokine serum levels in patients with plaque-type psoriasis. AV Roussaki-Schulze, C Kouskoukis, E Petinaki, E Klimi, E Zafiriou, ... International journal of clinical pharmacology research 25 (4), 169-173, 2005 | 74 | 2005 |
| Prevalence of pediculosis capitis among schoolchildren in Greece and risk factors: a questionnaire survey V Soultana, P Euthumia, M Antonios, RS Angeliki Pediatric Dermatology 26 (6), 701-705, 2009 | 68 | 2009 |
| Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study DF Murrell, A Patsatsi, P Stavropoulos, S Baum, T Zeeli, JS Kern, ... British Journal of Dermatology 185 (4), 745-755, 2021 | 61 | 2021 |
| Curcumin mediates attenuation of pro-inflammatory interferon γ and interleukin 17 cytokine responses in psoriatic disease, strengthening its role as a dietary immunosuppressant DΝ Skyvalidas, A Mavropoulos, S Tsiogkas, E Dardiotis, C Liaskos, ... Nutrition Research 75, 95-108, 2020 | 52 | 2020 |
| Successful Treatment of Condylomata Acuminata and Bowenoid Papulosis With Subcutaneous Injections of Low-Dose Recombinant Interferon-a G Gross, A Roussaki, E Schöpf, EM De Villiers, U Papendick Archives of dermatology 122 (7), 749-750, 1986 | 51 | 1986 |
| Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%. E Rallis, A Nasiopoulou, C Kouskoukis, A Roussaki-Schulze, ... Drugs under experimental and clinical research 31 (4), 141-145, 2005 | 50 | 2005 |
| Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis A Mavropoulos, E Zafiriou, T Simopoulou, AG Brotis, C Liaskos, ... Rheumatology 58 (12), 2240-2250, 2019 | 48 | 2019 |
| High serum levels of HIF-1α in psoriatic patients correlate with an over-expression of IL-6 Y Vasilopoulos, F Sourli, E Zafiriou, E Klimi, M Ioannou, Z Mamuris, ... Cytokine 62 (1), 38-39, 2013 | 38 | 2013 |
| Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen … G Gross, A Roussaki, S Baur, M Wiegand, A Mescheder Genitourinary Medicine 72 (1), 71, 1996 | 38 | 1996 |
| A pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment response in patients with psoriasis in the Greek population Y Vasilopoulos, C Sarri, E Zafiriou, A Patsatsi, C Stamatis, E Ntoumou, ... The Pharmacogenomics Journal 14 (6), 523-525, 2014 | 35 | 2014 |
| Increased HIF‐1 alpha immunostaining in psoriasis compared to psoriasiform dermatitides M Ioannou, F Sourli, I Mylonis, S Barbanis, R Papamichali, E Kouvaras, ... Journal of cutaneous pathology 36 (12), 1255-1261, 2009 | 35 | 2009 |
| Efficacy of Interferons on Bowenoid Papulosis and Other Precancerous Lesions. G Gross, A Roussaki, U Papendick Journal of investigative dermatology 95, 1990 | 32 | 1990 |
| Effect of TNF-α inhibitors on transcriptional levels of pro-inflammatory interleukin-33 and Toll-like receptors-2 and-9 in psoriatic plaques DP Vageli, A Exarchou, E Zafiriou, PG Doukas, S Doukas, ... Experimental and Therapeutic Medicine 10 (4), 1573-1577, 2015 | 31 | 2015 |
